Gemcitabine Injection IP 1gm
Gemcitabine Injection IP 1gm

Gemcitabine Injection IP 1gm

Price 1000 INR/ Box

MOQ : 1 Box

Gemcitabine Injection IP 1gm Specification

  • Dosage Form
  • As Per Suggestion
  • Origin
  • India
  • Feature
  • Other
  • Ingredients
  • Other
  • Application
  • Other
  • Storage Instructions
  • Cool & Dry Place
  • Shelf Life
  • 2 Years
 

Gemcitabine Injection IP 1gm Trade Information

  • Minimum Order Quantity
  • 1 Box
  • FOB Port
  • Delhi, Mumbai
  • Payment Terms
  • Paypal, Letter of Credit (L/C), Western Union, Letter of Credit at Sight (Sight L/C), Cash Advance (CA), Telegraphic Transfer (T/T), Cash in Advance (CID), Cheque
  • Supply Ability
  • 10000 Boxes Per Month
  • Delivery Time
  • 7 Days
  • Packaging Details
  • Per pack 1 vial
  • Main Export Market(s)
  • Australia, North America, Eastern Europe, Middle East, Africa, Western Europe, Central America, South America, Asia
  • Main Domestic Market
  • All India
 

About Gemcitabine Injection IP 1gm

A drug called gemcitabine Injection IP 1gm is used to treat cancer. It includes Gemcitabine, a nucleoside analogue that prevents DNA synthesis and slows the growth of cancer cells. It is frequently used to treat a number of cancers, including pancreatic, lung, breast, ovarian, and bladder cancer. The injection is given into the bloodstream. Gemcitabine can be used alone or in conjunction with other chemotherapy medications because of its method of action, which targets rapidly dividing cancer cells. However, it could result in negative side effects like fatigue, nausea, and bone marrow suppression. The kind and stage of the malignancy, as well as the patient's general health, are used to establish the dosage and administration schedule.

Gemcitabine Injection IP 1gm Features:

1. The injection's main component, gemcitabine, a nucleoside analogue of deoxycytidine, is the active component.

2. The injection is offered in a 1gm strength, ensuring accurate administration and dosing.

3. Gemcitabine is delivered intravenously, allowing for effective distribution throughout the body and the targeting of cancer cells.


Potential advantages

1. A broad range of tumours are treated with gemcitabine, including pancreatic, lung, breast, ovarian, and bladder cancer. It works well against a variety of tumour types.

2. DNA Synthesis Interference: Gemcitabine interferes with DNA synthesis in cancer cells that divide quickly, killing the cells and halting cancer progression.

3.Combination Therapy: To improve treatment outcomes and boost overall cancer treatment effectiveness, it may be administered alone or in combination with other chemotherapy medications.

4. Palliative Care: Gemcitabine can be used to treat advanced or metastatic cancers in order to reduce their symptoms and enhance the patient's quality of life.

5. Adjuvant Therapy: After surgery or main treatment, it may occasionally be used as adjuvant therapy to assist lower the risk of cancer recurrence.

6. Gemcitabine is a great asset in oncology because of its adaptability, which enables it to be employed as a therapy option for a variety of tumours.

Always speak with an oncologist or other healthcare professional to learn more about the specific advantages and potential hazards of Gemcitabine Injection IP 1gm in your particular situation. Since each patient's response to therapy can differ, individualised medical guidance is crucial for providing the best possible cancer care.

Gemcitabine Injection IP 1gm Uses:

The main application of gemcitabine injection IP 1gm is to treat different cancers. It is recommended for:

1. For the treatment of advanced or metastatic pancreatic cancer, gemcitabine is frequently utilised.

2. Non-small cell lung cancer: It is used to treat non-small cell lung cancer, either alone or in conjunction with other chemotherapy drugs.

3. Breast Cancer: Gemcitabine may be used, especially in conjunction with other treatments, to treat advanced or metastatic breast cancer.

4. It is frequently used in conjunction with other medications to treat advanced or recurring ovarian cancer.

5. Gemcitabine is a drug that can be used to treat advanced or metastatic bladder cancer.

6. Treatment for some forms of soft tissue sarcomas is possible with this method.


Gemcitabine Injection IP 1gm Side Effects:

Gemcitabine can have a number of adverse effects, whose severity varies from patient to patient. Several frequent adverse effects include:

  1. Nausea and vomiting
  2. Fatigue and weakness
  3. Low blood cell counts (anemia, neutropenia, thrombocytopenia)
  4. Increased risk of infection
  5. Hair loss (temporary)
  6. Loss of appetite
  7. Skin reactions at the injection site
  8. Liver and kidney function changes
  9. Flu-like symptoms, such as fever and chills
Gemcitabine may potentially cause more serious side effects, such as allergic responses, liver or lung issues, and changes in heart function, in addition to the more typical ones. While you are receiving treatment, your healthcare professional will closely monitor you to address any potential issues.

Any troubling symptoms or side effects must be immediately discussed with your healthcare staff. They can offer you individualised counselling and support during your cancer treatment and, if necessary, modify your regimen to reduce side effects and maximise the advantages of Gemcitabine Injection IP 1gm.



Precision Cancer Therapy

Gemcitabine Injection IP 1gm is specially formulated as a precise treatment for cancer patients, employing Gemcitabine's targeted anti-cancer properties. Its liquid form allows for controlled intravenous administration, making it suitable for hospitals and approved clinics where professional supervision is assured. Each batch is produced in India to meet stringent safety and quality standards.


Safe Storage and Long Shelf Life

This medication requires careful storage between 2C and 8C in a cool, dry place to maintain its effectiveness. Adhering to these storage guidelines ensures the medicine's potency remains intact over its two-year shelf life. Proper storage also prevents potential degradation, safeguarding patients' well-being.

FAQ's of Gemcitabine Injection IP 1gm:


Q: How should Gemcitabine Injection IP 1gm be used for cancer treatment?

A: Gemcitabine Injection IP 1gm must be administered intravenously as directed by a physician experienced in cancer treatments. The dosage and frequency are tailored to each patient based on their condition and response.

Q: What is the benefit of using Gemcitabine Injection IP 1gm?

A: Gemcitabine is an effective anti-cancer agent used for multiple cancer types. It disrupts the growth of cancer cells and may help reduce tumor size or slow disease progression.

Q: When should Gemcitabine Injection IP 1gm be administered?

A: The timing and intervals of administration are determined by a healthcare professional according to a personalized treatment plan. It is typically given in a hospital or clinical setting.

Q: Where should Gemcitabine Injection IP 1gm be stored?

A: This medicine must be kept at 2C to 8C in a cool, dry place, preferably within a pharmacy or refrigerator designated for medications. Incorrect storage may compromise its effectiveness.

Q: What process is followed for the procurement and distribution of Gemcitabine Injection IP 1gm in India?

A: Gemcitabine Injection IP is manufactured in India and distributed through a network of suppliers, exporters, importers, and traders, ensuring availability in both domestic and international markets.

Q: What is included in the formulation of Gemcitabine Injection IP 1gm?

A: Each unit contains 1gm of Gemcitabine as the active ingredient, formulated as a sterile liquid for intravenous use.

Q: Who should determine the dosage and usage of Gemcitabine Injection IP 1gm?

A: A qualified physician should always determine the appropriate dosage and frequency based on the patient's specific medical condition and overall health profile.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injection Category

Holoxan Ifosfamide 1 gm Mesna Uromitexan

Holoxan Ifosfamide 1 gm Mesna Uromitexan

Price 500 INR / Box

Minimum Order Quantity : 1 Bottle

Shelf Life : 2 Years

Dosage Form : As Per Suggestion

Origin : India

Application : Other

Canmab Trastuzumab 440mg Injection

Canmab Trastuzumab 440mg Injection

Price 35000 INR / Box

Minimum Order Quantity : 1 Unit

Shelf Life : 2 Years

Dosage Form : As Per Suggestion

Origin : India

Application : Other

Bleocel Bleomycin 15IU Injection

Bleocel Bleomycin 15IU Injection

Price 350 INR / Box

Minimum Order Quantity : 1 Box

Shelf Life : 2 Years

Dosage Form : As Per Suggestion

Origin : India

Application : Other

Kemocarb Carboplatin 450 Mg Injection

Kemocarb Carboplatin 450 Mg Injection

Price 2000 INR / Box

Minimum Order Quantity : 1 Box

Shelf Life : 2 Years

Dosage Form : As Per Suggestion

Origin : India

Application : Other



Back to top